Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

CUSIP: 877619106

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
275,000,000
Total 13F shares
19,436,846
Share change
+391,416
Total reported value
$361,910,267
Price per share
$18.62
Number of holders
48
Value change
+$4,396,852
Number of buys
25
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 877619106?
CUSIP 877619106 identifies TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
2.1%
5,687,616
$120,577,000 30 Jun 2021
13F
BlackRock Finance, Inc.
13F
Company
1.1%
2,966,771
$62,897,000 30 Jun 2021
13F
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
13F
Company
0.51%
1,391,190
$29,493,000 30 Jun 2021
13F
FRANKLIN RESOURCES INC
13F
Company
0.47%
1,305,846
$27,684,000 30 Jun 2021
13F
Artal Group S.A.
13F
Company
0.38%
1,040,882
$22,067,000 30 Jun 2021
13F
SANDS CAPITAL MANAGEMENT, LLC
13F
Company
0.26%
724,873
$15,367,000 30 Jun 2021
13F
TimesSquare Capital Management, LLC
13F
Company
0.25%
683,400
$14,488,000 30 Jun 2021
13F
Alphabet Inc.
13F
Company
0.23%
640,882
$13,587,000 30 Jun 2021
13F
VANGUARD GROUP INC
13F
Company
0.23%
628,644
$13,327,000 30 Jun 2021
13F
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
13F
Company
0.18%
500,000
$10,600,000 30 Jun 2021
13F
Nantahala Capital Management, LLC
13F
Company
0.16%
432,072
$9,160,000 30 Jun 2021
13F
Octagon Capital Advisors LP
13F
Company
0.12%
320,440
$6,793,000 30 Jun 2021
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.12%
320,440
$6,793,000 30 Jun 2021
13F
STATE STREET CORP
13F
Company
0.12%
318,619
$6,755,000 30 Jun 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.1%
263,442
$5,584,000 30 Jun 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.08%
213,646
$4,528,000 30 Jun 2021
13F
NORTHERN TRUST CORP
13F
Company
0.07%
198,859
$4,216,000 30 Jun 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.03%
87,030
$1,846,000 30 Jun 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.03%
80,422
$1,705,000 30 Jun 2021
13F
Bank of New York Mellon Corp
13F
Company
0.02%
56,672
$1,202,000 30 Jun 2021
13F
Granite Point Capital Management, L.P.
13F
Company
0.02%
50,000
$1,060,000 30 Jun 2021
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.01%
37,640
$798,000 30 Jun 2021
13F
Swiss National Bank
13F
Company
0.01%
37,500
$795,000 30 Jun 2021
13F
MORGAN STANLEY
13F
Company
0.01%
36,106
$766,000 30 Jun 2021
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.01%
33,822
$717,000 30 Jun 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
30,712
$651,000 30 Jun 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.01%
30,165
$639,000 30 Jun 2021
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.01%
28,800
$611,000 30 Jun 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
24,379
$517,000 30 Jun 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
19,174
$406,000 30 Jun 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.01%
18,671
$396,000 30 Jun 2021
13F
DAVENPORT & Co LLC
13F
Company
0.01%
13,750
$292,000 30 Jun 2021
13F
DEUTSCHE BANK AG\
13F
Company
0%
13,522
$286,000 30 Jun 2021
13F
CREDIT SUISSE AG/
13F
Company
0%
13,373
$283,000 30 Jun 2021
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0%
12,965
$275,000 30 Jun 2021
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0%
12,474
$264,000 30 Jun 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0%
11,448
$243,000 30 Jun 2021
13F
MetLife Investment Management, LLC
13F
Company
0%
9,509
$201,591 30 Jun 2021
13F
VIRTUS ADVISERS, LLC
13F
Company
0%
8,697
$184,000 30 Jun 2021
13F
UBS Group AG
13F
Company
0%
5,300
$112,000 30 Jun 2021
13F
Legal & General Group Plc
13F
Company
0%
3,749
$80,000 30 Jun 2021
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
1,745
$37,000 30 Jun 2021
13F
ROYAL BANK OF CANADA
13F
Company
0%
1,525
$32,000 30 Jun 2021
13F
CITIGROUP INC
13F
Company
0%
1,371
$29,000 30 Jun 2021
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0%
1,021
$22,000 30 Jun 2021
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
976
$21,000 30 Jun 2021
13F
RBC Europe Ltd
13F
Company
0%
250
$5,300 30 Jun 2021
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
241
$5,000 30 Jun 2021
13F

Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) as of Q3 2021

As of 30 Sep 2021, Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,436,846 shares. The largest 10 holders included FMR LLC, BlackRock Inc., FRANKLIN RESOURCES INC, Nantahala Capital Management, LLC, UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO, Artal Group S.A., VANGUARD GROUP INC, Sands Capital Ventures, LLC, TimesSquare Capital Management, LLC, and Alphabet Inc.. This page lists 48 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
48
Q3 2021 holders
48
Holder diff
0
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.